Cell therapy for heart recovery with LVAD support
Part of Heart & circulation clinical trials.
This trial tests whether injecting special cells (cell therapy) can help the heart recover in people with advanced heart failure who are getting a mechanical heart pump (LVAD). It may offer a new way to improve heart function and quality of life.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 65 years old.
- You have a type of heart muscle disease called non-ischemic dilated cardiomyopathy (not caused by blocked arteries).
- You are accepted to receive a left ventricular assist device (LVAD) – a mechanical pump to help your heart.
- You have been on the best-tolerated heart failure medications for at least 2 months.
- You do not have active infections, severe kidney or liver disease, or certain blood disorders.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a treatment made from stem cells that are turned into heart muscle cells and injected directly into the heart. It is for people with advanced heart failure who are already on the best available medicines and who are scheduled to have bypass surgery.
This trial tests whether injecting special heart muscle cells (made from stem cells) during a heart bypass or a heart pump surgery can help improve your heart's function. It is for people with severe heart failure who are already planning one of these surgeries.
This trial tests whether placing a special membrane with stem cells on the heart during bypass surgery can help improve heart function in people with a weak heart after a previous heart attack.
This study tests whether taking a small amount of your own belly fat (through liposuction), processing it, and injecting the cells back into your heart can improve heart function in people with chronic heart failure due to blocked arteries. The trial is for patients whose heart pumps weakly (ejection fraction of 40% or less) and who are already on standard medications.
This trial tests whether injecting lab-grown heart cells into the heart can help people with heart failure whose heart pumps less than 40% of normal. It may help improve heart function and reduce symptoms.
This study tests an experimental cell therapy called MiSaver that may help heart muscle recover after a heart attack. It's for people whose hearts are weak and who cannot have usual procedures like stents or bypass surgery.
Hear when a new Heart failure trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.